Pentafluorophenyloxy Compound, and Nonaqueous Electrolyte Solution and Lithium Secondary Battery Using Same
申请人:Abe Koji
公开号:US20080107969A1
公开(公告)日:2008-05-08
[Problem] To provide a novel pentafluorophenyloxy compound, a method for producing same, a nonaqueous electrolyte solution capable of forming a lithium secondary battery having excellent battery characteristics such as electrical capacity, cycling property and storage property, and a lithium secondary battery.
[Means for Solution] A pentafluorophenyloxy compound represented by the general formula (I) shown below, a method for producing same, a nonaqueous electrolyte solution containing same and a lithium secondary battery:
wherein R
1
represents a —COCO— group, a S═O group or a S(═O)
2
group, R
2
represents an alkyl group, a cycloalkyl group, an alkenyl group, an alkynyl group, an aryl group or an aralkyl group with the proviso that at least one of the hydrogen atoms of R
2
may be each substituted with a halogen atom and that R
2
does not represent an aryl group when R
1
represents a —COCO— group.
Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents
申请人:Kohn Harold L.
公开号:US20120232015A1
公开(公告)日:2012-09-13
A first aspect of the invention is a compound (sometimes also referred to herein as an “active agent” or “active compound”) of Formula Ia, or more particularly Formula Ib, or a pharmaceutically acceptable salt or prodrug thereof. Compositions thereof and methods of using the same (e.g. for the treatment of a neurological disease) are also described.
Renin inhibiting compounds containing a single a-amino acid of the formula:
and analogs thereof which inhibit the substrate-cleaving acting of renin, pharmaceutical compositions containing these compounds, processes for producing the compounds and methods of treating hypertension which employ the novel renin inhibitors.